Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Feedback Inhibition00:46

Feedback Inhibition

56.8K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.8K
Enzyme Inhibition01:30

Enzyme Inhibition

91.2K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

16.9K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.9K
GPCR Desensitization01:12

GPCR Desensitization

7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effective Treatment using Bumped Kinase Inhibitor 1708 in a Calf Clinical Model of Cryptosporidiosis.

The Journal of infectious diseases·2026
Same author

CliPepPI: Scalable prediction of domain-peptide specificity using contrastive learning.

bioRxiv : the preprint server for biology·2026
Same author

<i>In vitro</i> activity of MRS-2541, a novel MetRS inhibitor, against a selection of resistant gram-positive organisms associated with serious hospital infections.

Microbiology spectrum·2026
Same author

Versatile roles of inositol hexakisphosphate in the ubiquitin-proteasome system.

Essays in biochemistry·2026
Same author

CSN5i-3 is an orthosteric molecular glue inhibitor of COP9 signalosome.

Nature·2026
Same author

PCMT1 generates the C-terminal cyclic imide degron on CRBN substrates.

Nature chemical biology·2025

相关实验视频

Updated: Jan 8, 2026

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

3.2K

整形分子粘合剂抑制COP9信号体,具有基质依赖的功效.

Huigang Shi1, Xiaorong Wang2, Clinton Yu2

  • 1Department of Pharmacology, Box 357280, University of Washington, Seattle, WA 98195, USA.

bioRxiv : the preprint server for biology
|December 17, 2025
PubMed
概括

整形抑制剂通过分子合机制,意外地获得了基质依赖的功效. 这一发现引入了一类新型的酶抑制剂,称为"orthosteric分子抑制剂".

更多相关视频

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.9K
Comparing the Affinity of GTPase-binding Proteins using Competition Assays
10:37

Comparing the Affinity of GTPase-binding Proteins using Competition Assays

Published on: October 8, 2015

9.6K

相关实验视频

Last Updated: Jan 8, 2026

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

3.2K
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.9K
Comparing the Affinity of GTPase-binding Proteins using Competition Assays
10:37

Comparing the Affinity of GTPase-binding Proteins using Competition Assays

Published on: October 8, 2015

9.6K

科学领域:

  • 生物化学 生物化学
  • 酶学 是一种酶学.
  • 分子生物学分子生物学

背景情况:

  • 整形抑制剂结合酶活性位点,直接与基质竞争.
  • 由于它们的直接竞争机制,一般认为基质依赖性不太可能发生在奥索斯特抑制剂中.

研究的目的:

  • 为了研究CSN5i-3的意外基质依赖功效,它是COP9信号酶体 (CSN) 的正经抑制剂.
  • 阐明这种基质依赖的基础分子机制,并建立一个新的类型的酶抑制剂.

主要方法:

  • 酶抑制试验证实了CSN5i-3对CSN的活性.
  • 低温电子显微镜 (Cryo-EM) 用于确定酶-基质-抑制剂复合物的结构.
  • 生物化学试验分析蛋白质与蛋白质相互作用和结合亲缘关系.

主要成果:

  • CSN5i-3通过与基质竞争的CSN5活性位点结合来抑制COP9信号体 (CSN).
  • 尽管对自由CSN的亲和力很低,但CSN5i-3通过作为分子剂来实现纳米分子功效,稳定了CSN5和NEDD8.8之间的相互作用.
  • 冷-EM结构显示,CSN5i-3桥接了基质和酶,通过合作的三分子组件增强了结合亲和力.

结论:

  • 一个分子合机制赋予基质依赖的功效,以 orthosteric 抑制剂 CSN5i-3.
  • 这种机制突出显示,分子可以有效地运行在适度的个体蛋白质结合亲和力.
  • 这项研究确立了"正性分子抑制剂"作为一种新型的基质依赖酶对抗剂.